Clinical Trial Update: Risk of Chemotherapy Toxicity in Older Patients With Blood Cancer or Non-small Cell Lung Cancer

View source ↗

Summary

This clinical trial update discusses the risk of chemotherapy toxicity in older patients with hematologic malignancies or non-small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hematologic Malignancy
• Non-small Cell Lung Cancer

Snippet

Sponsor: Ohio State University Comprehensive Cancer Center | Conditions: Hematopoietic and Lymphoid Cell Neoplasm, Lung Non-Small Cell Carcinoma | Status: COMPLETED